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a b s t r a c t
Autophagy, a stress response activated in inﬂuenza A virus infection helps the cell avoid apoptosis.
However, in the absence of apoptosis infected cells undergo vastly expanded autophagy and nevertheless
die in the presence of necrostatin but not of autophagy inhibitors. Combinations of inhibitors indicate
that the controls of protective and lethal autophagy are different. Infection that triggers apoptosis also
triggers canonical autophagy signaling exhibiting transient PI3K and mTORC1 activity. In terminal
autophagy phospho-mTOR(Ser2448) is suppressed while mTORC1, PI3K and mTORC2 activities increase.
mTORC1 substrate p70S6K becomes highly phosphorylated while its activity, now regulated by mTORC2,
is required for LC3-II formation. Inhibition of mTORC2/p70S6K, unlike that of PI3K/mTORC1, blocks
expanded autophagy in the absence of apoptosis but not moderate autophagy. Inhibitors of expanded
autophagy limit virus reproduction. Thus expanded, lethal autophagy is activated by a signaling mechanism
different from autophagy that helps cells survive toxic or stressful episodes.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Inﬂuenza A virus is a major, worldwide, often lethal pathogen
(Taubenberger and Morens, 2008). Inﬂuenza A virus infection of
epithelial, lung and immune cells unconditionally leads to cell
death. Autopsies of deceased inﬂuenza-infected individuals reveal
inﬂuenza A virus in damaged tissue and in proximate immune
cells (Gill et al., 2010). Damage in lung tissue had often been
conventionally described as necrotic based on the morphology of
cells in tissue sections. Although it remains unclear if the necrosis
observed during autopsies is primary or secondary, several reports
from both in-vivo and in-vitro studies have shown virus induced
apoptotic cell death. Since the demonstration of apoptosis in-vivo
in the lungs and thymus of inﬂuenza A virus infected mice (Mori
et al., 1995) and liver, kidney and brain of chicken (Ito et al., 2002)
the mainstream view of the mechanism behind the pathology of
inﬂuenza A virus infection has focused mainly on apoptosis-
mediated damage. Moreover, elevated lysosomal activity and an
abundance of autophagosomes observed when apoptosis is inhib-
ited suggest the involvement of other death mechanisms during
infection (Kim et al., 2006; Yang and Chien 2009; McLean et al.,
2009).
Focus on how apoptosis is induced by the virus has resulted in
the identiﬁcation of several viral proteins, such as NS1, NA, PB1-F2
and M2 as mediators of virus-induced apoptosis (Zhang et al.,
2010; Chen et al., 2001; Ilyinskii et al., 2008). Host proteins with
associated cell death functions (e.g. caspases, VDAC, ANT3, NF-κB,
Bcl-2, Bax and Bak) also play important roles during infection
(McLean et al., 2009; Nencioni et al., 2009; Zhirnov et al., 1999;
Zhirnov and Klenk, 2009; Zamarin et al., 2005; Olsen et al., 1996).
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Although the importance of viral and host factors in inﬂuenza-
induced cell death is well documented, the mechanism of inter-
action for viral and host proteins is not well understood. PB1-F2
and M2 target the mitochondria through an unknown mechanism
eventually disrupting function and activating mitochondria
mediated apoptotic signaling (Zamarin et al., 2005; Aweya et al.,
2013). Moreover, the control of Bax and Bak levels during infection
to ensure nuclear fragmentation and release of viral nucleopro-
tein–RNA complexes to the cytosol remains unclear (McLean et al.,
2009).
Cell fate during stress is decided by the activation of several
signaling pathways. Autophagy, a major survival response acti-
vated in stressed cells, is a highly conserved process in eukaryotes
(Yorimitsu and Klionsky, 2005), and several molecules or com-
plexes can up- or down-regulate autophagy by interacting with
members of the autophagy pathway. Induction of autophagy can
occur through Class 1 PI3K (PI3K-1) and mammalian target of
rapamycin complex 2 (mTORC2) or through mammalian target of
rapamycin complex 1 (mTORC1). PI3K-1/mTORC2 signaling phos-
phorylates Akt in response to extracellular ligands (Jiang and Liu,
2008). Akt then phosphorylates mTOR at Serine 2448 and activates
mTORC1 (Sekulic et al., 2000), which inhibits autophagy by
targeting autophagy related protein (ATG) 13 (Corradetti and
Guan, 2006). In contrast, mTOR can alternatively induce autop-
hagy by activating p70S6K in Drosophila fat bodies (Scott et al.,
2004), although this situation remains unexplained. Two viral
proteins, Inﬂuenza NS1 and M2, have been recently associated
with autophagy signaling. NS1 binds to p85β, the regulatory
subunit of PI3K (Hale et al., 2006), while M2 keeps autophagy at
moderate levels by limiting the degree of lysosome fusion with
autophagosomes (Gannage et al., 2009). Autophagy, originally
characterized as critical for inﬂuenza replication (Zhou et al.,
2009), was later identiﬁed to limit the apoptotic response to
infection without affecting virus reproduction (Gannage et al.,
2009). However, elimination of inﬂuenza-induced apoptosis does
not halt virus-induced cell death; instead, an increase in the
autophagic state occurs, thus indicating alternative routes to
inﬂuenza-mediated cell death (McLean et al., 2009).
Here we show that inﬂuenza A virus induces autophagy during
infection subsequent to activation of canonical autophagy signal-
ing. This induction occurs as apoptotic signaling and death
progresses. When cells are unable to undergo apoptosis, infected
cells still die, but they exhibit vastly expanded autophagy with
robust lysosome turnover. This alternative cell death is not
necroptosis. The increased autophagic state manifests altered
autophagy signaling with increased mTORC1 and PI3K/mTORC2
activity and p70S6K phosphorylation; while blocking PI3K,
mTORC2 or p70S6K activity prevents lethal autophagy and
decreases infectious virus production. Our results indicate an
underlying role and mechanism for autophagy during inﬂuenza
A virus infection. Inﬂuenza A virus can still kill cells and reproduce
even if apoptosis is impeded.
Results
Inﬂuenza A virus infection triggers autophagy
Inﬂuenza A virus infection triggers autophagy in various cell types
(McLean et al., 2009; Zhou et al., 2009). To understand the mechan-
ism by which inﬂuenza A virus induced autophagy is triggered we
examined canonical autophagy signaling in inﬂuenza A virus
(MOI¼5) infected MDCK cells, which is a mammalian cell line that
is both permissive to infection and able to undergo autophagy. We
evaluated autophagy by western blot using anti-LC3 antibody. As
shown in Fig. 1A, by 8 hours post infection (HPI), 18 kDa LC3-I
increases dramatically, and reaches a maximum in 10 HPI. We also
ﬁnd a gradual increase in 16 kDa LC3-II, which persists through
24 HPI. These changes are not observed in mock-infected cells
(Fig. 1B) and indicate increased autophagy during infection.
Lysosome turnover of autophagosomes, which can be mea-
sured by levels of LC3-II after treatment with lysosome inhibitors
like pepstatin A, is the hallmark of functional autophagy (Tanida
et al., 2005; Mizushima et al., 2010). To determine if increased
autophagy during infection is not a result of autophagosome
accumulation due to decreased lysosome fusion or function, we
assessed LC3-II turnover in lysosomes after exposure of infected
cells to the inhibitor of lysosomal cathepsin D, pepstatin A (10 μg/ml),
for 24 HPI. Increase in LC3-II resulting from inﬂuenza A virus infection
was even higher following treatment with pepstatin A, indicating that
autolysosomes were turning over, i.e. that they were functional
(Fig. 1C LC3). Mock-infection, where cells treated with virus diluting
media without virus then given new media, only show low-level
autophagosome turn over indicative of housekeeping autophagy
(Fig. 1C þDMSO IAVþpepstatin).
Inﬂuenza A infection triggers apoptosis
Inﬂuenza A virus kills various types of cells (Taubenberger and
Morens, 2008; Gill et al., 2010; Mori et al., 1995; Ito et al., 2002;
Fig. 1. Inﬂuenza A virus activates the autophagy pathway. (A) Upper panel: western
blot using whole cell lysates from MOI¼5 inﬂuenza A infected MDCK cells at 3, 6, 8,
10 and 24 HPI demonstrating the start of 18 kDa LC3-I build-up at 8 HPI, indicating
induction of autophagy. 16 kDa LC3-II begins to increase shortly thereafter. (B) This is
not observed in mock-infected samples. (C) Exposure of MDCK cells to 10 μg/ml of
pepstatin A increases LC3-II relative to β-tubulin (numbers¼ratio) in mock-infected
and inﬂuenza virus infected cells after 24 HPI, indicating that autophagy is functional
in both mock-infected (þDMSOþpepstatin A) and infected cells (þDMSOþ
IAVþpepstatin A). β-tubulin was used as loading control (A–C β-tubulin).
E. Datan et al. / Virology 452-453 (2014) 175–190176
McLean et al., 2009; Zhang et al., 2010; Chen et al., 2001; Nencioni
et al., 2009; Zamarin et al., 2005; Morris et al., 1999; Mohsin et al.,
2002; Wurzer et al., 2003; Wurzer et al., 2004), typically over
several days (Fig. 2A). Most of the dying infected cells manifest
fragmented nuclei, a characteristic of apoptotic cells while mock-
infected cells show minimal cell death and nuclear fragmentation
(Fig. 2A, compare þ IAV to m). We conﬁrmed death by apoptosis by
examining the DNA of infected cells. Unlike mock-infected cells, by
24 HPI infected cells have substantial cleavage of DNA (Fig. 2B).
We also found, by western blot, that several caspases, including
caspase 3 but also caspase 8, which is normally activated by a cell
surface receptor–ligand interaction, are activated (Fig. 2C and D).
PARP was also cleaved in a manner typical of caspase-3 (Fig. 2E).
We conclude that, even though autophagy is very active during
inﬂuenza infection, the vast majority of infected cells undergo
apoptosis.
Cell death with increased autophagy occurs after apoptosis
is inhibited and is not necroptosis
Inhibition of caspases during exposure to toxins often blocks
apoptosis (Lockshin and Zakeri, 2002). To examine the role of
apoptosis in inﬂuenza-induced death we used caspase 3-deﬁcient
MCF7 cells, which are also permissive to inﬂuenza A virus as shown
by increasing infectious inﬂuenza virus production (Fig. 3A right).
Consistent with the above results in MDCKs inﬂuenza slowly kills
MCF7 cells but unlike MDCKs fewer MCF7 cells manifest nuclear
fragmentation than membrane permeability (Fig. 3A left). The
modest nuclear fragmentation may derive from activation of other
caspases by inﬂuenza infection (McLean et al., 2009) making
caspase 3-deﬁcient MCF7s inappropriate for the study of apoptosis
inhibition during infection. To induce a more general caspase
blockage we opted for broad acute inhibition of caspases using
zVAD-fmk (zVAD).
At 50 μM, pancaspase inhibitor zVAD-fmk completely inhibits
activation of caspases 3 and 8 (Fig. 3B and C) in MDCKs even
though it only modestly inhibits cell death as measured by trypan
blue (Fig. 3D, nPo0.05). Virus replication was identical to that
seen in the absence of zVAD (Fig. 3F). However as opposed to
deﬁciency of caspase 3 alone in MCF7 cells, zVAD completely
blocked virus-induced nuclear fragmentation even at almost 80%
cell death (Fig. 3E).
We therefore asked whether the dying cells underwent necrop-
tosis, which can be revealed by inhibition of apoptosis (Degterev
et al., 2005). We therefore used an inhibitor to necroptosis,
necrostatin (n). As previously shown, zVAD treatment of infected
MDCK cells modestly decreases cell death (Fig. 3G compare þ IAV–
inhib to þ IAVþzVAD, nPo0.05). Necrostatin at 50 μM did not
decrease cell death of infected, caspase-inhibited cells (Fig. 3G,
þ IAVþzVADþn50). On the contrary, increasing concentrations of
necrostatin to 100 and 200 μM increase cell death in infected,
caspase-inhibited (Fig. 3G, compare þ IAVþzVAD to þ IAVþzVADþ
n100 or n200) and uninfected samples (Fig. 3G –IAVþzVADþn50 to
n200). Thus we have no evidence for necroptosis in this system.
Excessive autophagy has also been reported to lead to cell
death (Tsujimoto and Shimizu, 2005). This possibility was assessed
by morphological examination of MDCK cells through electron
microscopy, which indicated the presence of autophagosomes that
are considerably larger and more numerous in infected, caspase-
inhibited cells (Fig. 3K) than those found in mock-infected, zVAD
control or infected cells without zVAD (Fig. 3H, I, and J respec-
tively). Additionally we ﬁnd by western blot of whole cell lysates
from samples identical to those used for electron microscopy that
LC3-II is higher when caspases in infected cells are inhibited
compared to infection without zVAD (Fig. 3L). Since cell death
persists after inhibition of either apoptosis or necroptosis we
therefore examined if increased autophagy was sufﬁcient to
explain the death of inﬂuenza infected caspase-inhibited cells.
Autophagy during alternative mode of death is massive
and functional
We blocked autophagy with the inhibitor Wortmannin (20 μm).
While this inhibitor alone failed to prevent death of infected cells
(Fig. 4A), the combination of the caspase inhibitor zVAD with
Wortmannin substantially and signiﬁcantly (Fig. 4A þ IAVþ
zVADþwort, nnnPo0.005) decreased the death of infected cells.
Even better protection was achieved with increased concentra-
tions of Wortmannin (data not shown). Moreover, cell death in
infected ATG 5 KO MEFs with zVAD is lower than in infected ATG
5 wild type with zVAD (Fig. S1, nnnPo0.005). Thus we conclude
that vastly expanded (massive) autophagy is a major contributor to
the death of caspase-inhibited infected cells.
To characterize autophagy during caspase inhibition, we com-
pared the timing of LC3 activation in infected cells with zVAD to
that seen in infected cells where caspases are functional. The
kinetics of LC3-I and II are quite different when caspases are
inhibited. Unlike infection in the presence of functional caspases,
where LC3-I increases by 8 HPI, followed by formation of LC3-II at
10 HPI (Fig. 1A LC3), LC3-I in infected cells with zVAD does not
increase while LC3-II very slowly increases (Fig. 4B LC3),
Fig. 2. Inﬂuenza infection induces apoptosis through activation of multiple
caspases. (A) Using MOI¼5 cell death in MDCK cells was assessed at various time
points using trypan blue exclusion. Infection with inﬂuenza results in 30% death by
24 HPI and most cells die after 48 HPI (black bars). Nuclear fragmentation of
infected MDCK cells, as analyzed by the Hoechst assay, also increases with
increasing virus exposure until all cells undergo nuclear fragmentation after
48 HPI (white bars). Data shown are means7S.E. for three independent experi-
ments per sample. Mock-infected MDCK cells have 20% death and nuclear
fragmentation after 48 HPI (A, m). Nuclear fragmentation in MDCK cells during
infection is coupled with DNA cleavage (B), which is absent in the mock-infected
condition ( IAV). Caspase 3 activation (D) and the extrinsic pathway initiator
caspase 8 (C) are also activated in infected MDCK cells showing activation of several
caspases. Pronounced caspase 3 cleavage of PARP is observed in infected MDCK
cells from 8 HPI onwards (E). Uncleaved caspase 8 and cleaved PARP serve as
internal loading control (C–E).
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Fig. 3. Broad caspase inhibition blocks inﬂuenza induced apoptosis and increases autophagy, but cells still die in a manner independent of programmed necrosis. Cell death
and apoptosis during inﬂuenza infection (MOI¼5) are not completely absent in caspase 3 deﬁcient MCF7 cells (A left). Infected MCF7 cells allow virus infection and robust
infectious virus production (A right). Cell death after 96 HPI in mock-infected MCF7 cells remains low (A, m). However, unlike caspase 3 deﬁcient MCF7, activation of multiple
caspases in MOI¼5 infected MDCK cells can be blocked with 50 μM zVAD as shown by the lack of active caspases 3 and 8 after zVAD treatment (B and C). Even 50 μM zVAD
inhibition of inﬂuenza-induced apoptosis as analyzed by trypan blue (D, *Po0.05) and the Hoechst assay (E) do not prevent death in infected MDCK cells. Mock-infected
MDCK cells show minimal cell death (D, m) and nuclear fragmentation (E, m). Inhibition of virus-induced apoptosis in 50 μM zVAD-treated MDCK cells does not affect virus
reproduction as measured by plaque assay (F). Treatment of infected, apoptosis-inhibited MDCK cells with 50, 100 or 200 μM of the inhibitor of programmed necrosis
necrostatin (n50–200) does not prevent death during apoptosis inhibition (G, *Po0.05). Electron microscopy of samples from mock-infected (H), zVAD control (I), infected
cells without zVAD (J) and inﬂuenza-infected MDCK cells with zVAD (K). After 24 HPI infected cells without inhibitor show nuclear fragmentation (J, white asterisk) and
increased vacuolization (J, black arrow). zVAD prevents inﬂuenza induced nuclear fragmentation (K, white arrow) but yields an increase in large autophagosomes (K, black
arrows). An intact nuclear membrane (H, white arrow) and few vacuoles in mock-infected cells (H, black arrow) indicate normal physiology. zVAD by itself does not alter cell
morphology, as mitochondria (I, mi), and cytoplasm remain normal in zVAD controls. To assess the state of autophagy after apoptosis inhibition we ran whole cell lysates
from infected MDCK cells with or without zVAD using SDS-PAGE and performed western blot. We conﬁrm an increase in autophagy after 24 HPI, as shown by LC3-II, in
zVAD-exposed infected cells compared to uninhibited infected cells or mock-infected and zVAD controls (L). Data for cell death, fragmentation and titers for MCF7 and MDCK
cells were means7S.E. of three independent experiments.
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suggesting immediate conversion of LC3-I to LC3-II. LC3-II sharply
increases at 24 HPI and persists, though declining slowly, through
48 HPI. Infected cells exposed to zVAD contain numerous autop-
hagosomes at various stages of maturity (Fig. 4C: left: overview,
right top: early, right middle: middle, and right bottom: late)
demonstrating normal autophagosome formation and turnover to
lysosomes. As measured by acid phosphatase, lysosomes are
functional but activated later in inﬂuenza infection with zVAD
(Fig. 4D, IþZ) compared to infection without the caspase inhibitor
(Fig. 4D, I). Furthermore, inhibition of cathepsin D by pepstatin A
(10 μg/ml) leads to accumulation of LC3-II (Fig. 4E LC3) indicating
that autophagosomes fuse with lysosomes for degradation (Tanida
et al., 2005; Mizushima et al., 2010). Thus when apoptosis is
blocked in infected cells, autophagy remains functional and its
massive increase is a major component in the eventual death
of cells.
Massive autophagy during alternative death depends on modiﬁed
autophagy signaling
Cell stress triggers autophagy through PI3K and mTOR signal-
ing. Inhibition of PI3K prevents autophagy, while inhibition or
knockdown/knockout of mTOR increases autophagy (Scott et al.,
2004; Ravikumar et al., 2010). We therefore examined the signal-
ing pathways that lead to induction of massive autophagy when
zVAD is present in infected cells. To do this we compared signaling
processes when autophagy is provoked by infection in the pre-
sence or absence of inhibition of apoptosis. Since Wortmannin
targets PI3 kinase, a ﬁrst step in autophagy signaling, we examined
the effect of Wortmannin on LC3 translocation and cleavage.
Wortmannin when added during infection alone blocks transloca-
tion of LC3 from cytoplasm to autophagosomes, as demonstrated
by the failure of formation of puncta (Fig. 5A, compare c to b and
quantitation in Fig. 5Af, compare IAV to IAVþW) and accumulation
of LC3-II (Fig. 5B and C LC3, compare IAV to IAVþwort 20–40 μM).
However, Wortmannin cannot completely block massive autop-
hagy when apoptosis is inhibited by zVAD. GFP-LC3 punctation is
still maintained (Fig. 5Ae and Af, compare IAVþZ to IAVþZþW)
and we see conversion of LC3-I to LC3-II by western blot (Fig. 5B
and C LC3, þ IAVþzVADþwort). Under these circumstances
we ﬁnd, as expected, active caspase 3 in infected cells without
zVAD (Fig. 5B aCaspase3þ IAV) and no detected active caspase
3 in mock-infected, treatment controls and infected cells with
apoptosis inhibitor (Fig. 5B aCaspase 3, –IAV, þzVAD, þwort,
Fig. 4. Massive autophagy in the absence of apoptosis is functional and lethal. (A) Inhibition of autophagy in zVAD-treated, infected cells with 20 μM PI3K inhibitor
Wortmannin (wort) decreases virus-induced death in MDCK cells by 48 HPI (*Po0.05, ***Po0.005) although some of infected cells still die in an alternative pathway.
Experiments were done in triplicates and data shown are means7S.E. for each sample. (B) Western blot using whole cell lysates from zVAD-exposed, infected MDCK cells
reveals increased autophagy at 24–36 HPI, gradually decreasing at 48 HPI relative to β-tubulin (numbers¼ratio). Samples from the experiments in Fig. 3H–K with 24 HPI
exposure to zVAD and inﬂuenza were ﬁxed for qualitative examination by electron microscopy of autophagosome degradation. Most vacuoles in caspase-inhibited, infected
MDCK cells resemble autophagosomes at various stages of degradation (C right: top, middle and bottom). Right panels of (C) represent enlargements of boxed areas
displaying: early (C right top, white arrowhead), middle (C right middle, white arrow) and late (C right bottom, white arrow) autophagosomes, which abound in zVAD-
exposed infected cells. Lysosome activity in infected MDCK cells as measured by acid phosphatase, a lysosomal enzyme, doubles after inﬂuenza infection (i) at 24 HPI
(D) compared to controls (c) and mock infected samples (m). Exposure to zVAD during infection (iþz) delays activation of lysosomes similar to infection alone (i) from 24 to
48 HPI independent of zVAD treatment alone (z). One unit of acid phosphatase activity¼1 mM freed 4 nitrophenylphosphate min1 mL1 and data shown are means7S.E.
of experiments done in triplicate. Treatment of infected MDCK cells with pepstatin A (p) increases LC3-II, indicating turnover of autophagosomes during infection with zVAD
(iþpþzVAD) compared to infection alone with or without pepstatin (i and iþp) or controls (m¼mock-infected, p, zVAD, pþzVAD) after 48 HPI (E LC3). Numbers below
blots represent ratios relative to β-tubulin (LC3II: β-tub).
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þ IAVþzVAD). Inhibition of autophagy in infected cells without
zVAD increased active caspase 3 relative to β-tubulin (Fig. 5B
aCaspase 3, þ IAVþwort) suggesting a role for autophagy in
limiting the apoptotic response to infection. Viral nucleoprotein
synthesis was not changed under any of these conditions (Fig. 5B
NP). Our ﬁndings with Wortmannin are similar to those observed
with class 3 PI3K and autophagy inhibitor 3MA where inhibition is
most pronounced in infection alone compared to inﬂuenza-zVAD
treatment (Fig. 5D LC3, bottom).
To further distinguish autophagy regulation in inﬂuenza-zVAD
treated cells from inﬂuenza treatment alone we evaluated the role
of mTOR in both situations. To do this we assessed mTORC1
activation through mTOR phosphorylation at Ser2448 (p-mTOR)
and activity by levels of phospho-p70S6K (Ravikumar et al., 2010).
To fully assess the role of mTOR during inﬂuenza infection we also
examined mTORC2 activity through phospho-Akt (p-Akt), which
PI3K also activates (Jiang and Liu, 2008; Ravikumar et al., 2010).
Treatment with zVAD by itself induces a modest level of p-Akt
from 1 to 6 HPI that gradually wanes by 10 HPI (Fig. 6A p-Akt,
þzVAD). No upregulation of p-mTOR is observed in zVAD treat-
ment control compared to mock-infected cells, which we treat
with virus media without virus then give new media as an
equivalent to 0 HPI or uninfected cells (Fig. 6A p-mTOR, þzVAD
compared to m). Treatment with zVAD increases the level of
phospho-p70S6K (p-p70S6K) compared to mock-infected samples
(Fig. 6A p-p70S6K, þzVAD compared to m).
Infected cells exposed to zVAD show an early increase in p-Akt
at Serine 473 after 3 HPI lasting until 10 HPI (Fig. 6B p-Akt)
suggesting increased mTORC2/PI3K activity compared to inﬂuenza
treatment alone. Inﬂuenza infection by itself, as shown in Fig. 6C,
transiently increases p-Akt after 6 HPI (Fig. 6C p-Akt). This phos-
phorylation eventually decreases as autophagosomes are formed
from 8 HPI onwards (Fig. 6C LC3). Total Akt in mock-infected, zVAD
treatment by itself and infection with zVAD does not change
(Fig. 6A and B Akt) compared to infection treatment alone where
Akt increases through at least 10 HPI (Fig. 6C Akt).
Fig. 5. Massive autophagy relies on alternative autophagy signaling. Punctation of GFP-LC3, a measure of autophagy, was assessed following inhibition of PI3K by
Wortmannin. Mock-infected cells (Aa and Af, m) transfected with GFP-LC3 have diffuse GFP-LC3 while infection leads to punctation (Ab, white arrow and Af, IAV).
Wortmannin blocks virus triggered punctation (Ac and Af compare IAV to IAVþW, *Po0.05) but not in the presence of zVAD (Ae) where punctation persists (white arrows).
Treatment with Wortmannin decreases the number of cells with puncta observed in infected cells exposed to zVAD (Ae and Af compare IAVþZ to IAVþZþW, **Po0.01)
compared to infection with zVAD alone (Ad, white arrow). (B) Examination of whole cell lysates using SDS-PAGE and antibody against LC3 (B LC3) conﬁrms results from
GFP-LC3 cytochemistry. Increasing Wortmannin from 20 μM to 30 and 40 μM leads to substantial decrease of LC3-II in infected cells with apoptosis but only moderately in
zVAD-exposed infected cells (C LC3). Wortmannin does not prevent zVAD from blocking virus-induced activation of caspase 3 (B aCaspase 3). Increased caspase 3, when
adjusted to protein loading, is observed in Wortmannin treated infected cells (B aCaspase 3, IAVþ20 wort). Treatment with 5–20 mM 3MA (3MA 5–20) shows that inhibition
of class 3 PI3K by 3MA can also effectively prevent autophagy during infection by itself but not during inﬂuenza-zVAD treatment (D LC3, bottom), as is the case with
Wortmannin. NP was used as infection control (B NP) while β-tubulin for loading (B–D β-tubulin). Numbers below blots represent ratios relative to β-tubulin.
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This brief increase of mTORC2/PI3K activity, as shown by p-Akt,
in infection without zVAD indicates an upstream role for mTORC2/
PI3K in autophagy signaling during inﬂuenza A virus infection,
which is well underway as shown by expression of virus nucleo-
protein starting at 6 HPI (Fig. 6C NP). However, unlike infection by
itself p-Akt is increased and sustained during infection with zVAD.
We therefore examined the involvement of mTORC1, which can
affect levels of p-Akt through feedback (Ravikumar et al., 2010),
in the induction of massive, lethal autophagy during inﬂuenza-
zVAD treatment by examining mTORC1 activation and activity.
The activation of mTORC1, as shown by phosphorylation of
mTOR at Serine 2448 and observed in infected MDCK cells from
6 to 10 HPI (Fig. 6C p-mTOR), is not the same as what we ﬁnd
during infection when caspases are inhibited (Fig. 6B p-mTOR).
When samples are normalized for protein loading we ﬁnd
substantial p-mTOR at 3 HPI, which is then downregulated to
undetectable levels by 24 HPI, at which time we see substantial
LC3-II levels (Fig. 6B LC3). Total mTOR remains essentially stable in
all conditions (Fig. 6A–C mTOR). Surprisingly, the dephosphoryla-
tion of mTOR at Ser2448 (thus deactivation of mTORC1 in infection
with zVAD) does not correlate with increased phosphorylation of
p70S6K (p-p70S6K) at Threonine 389, a target of mTORC1, com-
pared to infection without zVAD (compare Fig. 6B to C p-p70S6K).
Total p70S6K levels remain stable for both inﬂuenza alone and
inﬂuenza-zVAD treatments (Fig. 6A and B p70S6K).
To determine the state of mTORC1 activity during infection
with zVAD we re-examined mTORC1 mediated phosphorylation of
p70S6K at 10 HPI in infected, zVAD-treated cells after inhibition of
mTORC1. Treatment with rapamycin at 50 nM or torin1 at 2 nM
inhibits mTORC1 (Liu et al., 2010; Feldman et al., 2009). Rapamycin
inhibits p-p70S6K during inﬂuenza-zVAD treatment and in infec-
tion alone (Fig. 7A p-p70S6K, IAVþZþR and IAVþR). Low-level
Fig. 6. Altered mTOR/p70S6K signaling occurs during massive autophagy. To identify critical alterations in autophagy signaling responsible for massive autophagy during
MOI¼5 infection with zVAD we re-evaluated markers for PI3K and mTOR activity at various time points by western blot. No increased PI3K/mTORC2 activity (A p-Akt, M),
mTORC1 activation (A p-mTOR, M) or activity (A p-p70S6K, M) is observed in mock-infected MDCK samples. Changes in PI3K/Akt and mTOR signaling are observed during
massive autophagy. PI3K/mTORC2 activity is early and prolonged during massive autophagy (B p-Akt). Rapid phosphorylation after 3 HPI is observed in mTOR (B p-mTOR)
while phosphorylation of mTOR substrate p70S6K (B p-p70S6K) differs from that seen in infected without zVAD (C p-p70S6K), mock-infected and zVAD controls
(A p-p70S6K, M and þzVAD). Although zVAD controls show PI3K/mTORC2 activity and modiﬁcations in mTOR substrate phosphorylation, the absence of autophagy in zVAD
controls indicates these changes to be sub-threshold (A p-Akt and p-p70S6K, þzVAD). NP shows successful infection (B and C NP) while Akt and p70S6K served as mTOR
complex substrate controls. β-tubulin was used for loading control (A–C β-tubulin).
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p-p70S6K in mock-infected cells and increased p-p70S6K by zVAD
treatment alone are also blocked by rapamycin (Fig. 7A p-p70S6K, R
and ZþR). To ensure inhibition by torin1 we used 4 nM during
mTORC1 inhibition and found that 4 nM torin1 inhibits only in the
presence of zVAD. Increased p-p70S6K in infected, zVAD-treated
cells is lowered by 4 nM torin1 compared to torin1 treatment in
infection alone (Fig. 7A p-p70S6K, compare IAVþZþT to IAVþT).
Torin1 also decreased p-p70S6K in zVAD control (Fig. 7A
p-p70S6K, ZþT). Total p70S6K increases with treatments and
remains stable compared to mock-infected cells (Fig. 7A p70S6K,
compare all to M). The inhibition of p-p70S6K by mTORC1
inhibitors rapamycin and torin1 during infection with zVAD shows
that mTORC1 is active when inﬂuenza-induced autophagy
expands. As previously mentioned, to examine whether mTORC1
is part of the regulatory signals controlling expanded autophagy
during inﬂuenza-zVAD treatment, we examined LC3 levels at
24 HPI after mTORC1 inhibition. Rapamycin or torin1 partially
decrease LC3-II, thus inhibit autophagy, during inﬂuenza-zVAD
treatment (Fig. 7B LC3, IAVþZ compared to IAVþZþR or
IAVþZþT4nM). Correcting for loading, no inhibition is observed
in infection alone (Fig. 7B LC3, IAV compared to IAVþR or
IAVþT4nM). This shows that increased mTORC1 activity observed
during inﬂuenza-zVAD treatment, regardless of Ser2448 phos-
phorylation on mTOR, contributes the expansion of inﬂuenza-
induced autophagy. However, mTORC1 inhibition leads only to
partial inhibition of expanded autophagy suggesting the involve-
ment of other regulators.
To examine the nature of increased Akt phosphorylation at
Ser473 (p-Akt) during expanded autophagy we examined the
effect of known upstream Akt kinases mTORC1 and mTORC2 on
p-Akt (Ravikumar et al., 2010). Inhibition of mTORC1 with rapa-
mycin or 4 nM torin1, as shown in Fig. 7A, does not decrease p-Akt
in inﬂuenza-zVAD treated cells (Fig. 7C pAkt, IAVþZ compared to
IAVþZþR or IAVþZþT4nM) while mTORC2 inhibition by 20 nM
torin1 (Liu et al., 2010) like known p-Akt inhibitor 20 μM Wort-
mannin successfully decreases p-Akt to mock-infected levels
(Fig. 7C pAkt, M compared to IAVþZþT20nM or IAVþZþWort).
Total Akt in all treatments is increased and remains stable compared
to mock-infected condition (Fig. 7C Akt, all compared to M). The
sensitivity of p-Akt to mTORC2 or PI3K inhibitors and the persistence
Fig. 7. Massive autophagy requires mTOR/p70S6K activity. Inhibition of mTOR complexes or p70S6K and consequence on lethal autophagy was determined by western blot
using whole cell lysates from treatments with mTOR inhibitors. Treatment with 50 nM rapamycin (R) or 4 nM torin1 (T 4nM) inhibits robust mTORC1-mediated p70S6K T389
phosphorylation at 10 HPI (A p-p70S6K) but not expanded, lethal autophagy at 24 HPI (B LC3). PI3K/mTORC2 activity at 10 HPI persists after mTORC1 inhibition (C p-Akt,
IAVþZþR or IAVþZþT4nM) while treatment with 20 μM PI3K inhibitor Wortmannin (Wort) and mTORC2 inhibitor 20 nM torin1 (T 20nM) inhibited PI3K/mTORC2
mediated Akt phosphorylation (C p-Akt). Inhibition of mTORC2 effectively reduces lethal autophagy (D LC3, IAVþZþT20nM) and p70S6K activity at 24 HPI as estimated by
Bcl2 levels during inﬂuenza-zVAD treatment (D Bcl-2, IAVþZþT20 nM). p70S6K activity inhibitor bis-indolylmaleimide V (P70i) prevents LC3-I conversion to LC3-II only
during massive autophagy (E LC3, IAVþZþP70i 100 μM). This outcome is independent of PKC inhibition (see Results) since the loss of p-Erk1/2 at 100 μM never results in
LC3-I build up in treatment control and in apoptosis-competent infected cells (E LC3, P70i 100 μM and IAVþP70i 100 μM). α or β-tubulin was used for loading control
(A–E α or β-tubulin).
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of Serine 473 phosphorylation on Akt after mTORC1 inhibition show
that increased mTORC2 and PI3K activity during inﬂuenza-zVAD
triggered autophagy is independent of mTORC1 activity, which also
increases. Furthermore, inhibition of mTORC2 compared to that of
mTORC1 successfully decreases LC3-II, thus autophagy, in inﬂuenza-
zVAD treated cells (Fig. 7D LC3, IAVþZ compared to IAVþZþT20nM).
Torin1 at 20 nM slightly increased autophagy in infected cells with
active mTORC1 (Fig. 7D LC3, IAVþT20nM) suggesting inhibition of
mTORC1, which inhibits autophagy.
Although 4 nM of torin1 was as potent as rapamycin in
decreasing autophagy in inﬂuenza-zVAD treated cells the persis-
tence of p-p70S6K after treatment with 4 nM torin1 raised the
possibility of dose-dependent sensitivity of p70S6K phosphoryla-
tion to torin1. Since mTORC2 activity is increased during massive
autophagy and inhibited by 20 nM torin1 we examined the effect
of inhibition of mTORC2 (using torin1) on p70S6K. By estimating
the activity of p70S6K through levels of Bcl2 (Pastor et al., 2009) at
24 HPI, torin1 at inhibitory concentrations for mTORC2 decreased
Bcl2 only during massive autophagy but not in other conditions
(Fig. 7D Bcl2, IAVþZþT20nM). These results indicate the impor-
tance of mTORC1 and mTORC2 in the induction of inﬂuenza-
zVAD-induced massive autophagy and increased p70S6K activa-
tion, but not in induction of moderate autophagy in infection
treatment alone. Inﬂuenza nucleoprotein (Figs. 6B and C NP)
indicated successful infection while β and α-tubulin (Figs. 6 and 7
β or α-tubulin) documented equivalent loading. To summarize,
we interpret these results to indicate that massive induction of
autophagy after blockage of virus-induced apoptosis in this system
may be driven by the mTOR/p70S6K pathway, whereas autophagy
induction during infection without zVAD may be independent of
mTOR signaling.
p70S6K signaling is needed in massive autophagy
Noting the modiﬁcations in autophagy signaling and prono-
unced p70S6K phosphorylation, we explored the role of p70S6K
in inﬂuenza-induced autophagy. p70S6K controls the amount of
autophagy in Drosophila (Scott et al., 2004). To evaluate the role
of increased p70S6K phosphorylation just before massive autop-
hagy in infected, caspase-inhibited mammalian cells we inhibited
p70S6K activity with P70 inhibitor (P70i) bis-indolylmaleimide V
(Marmy-Conus et al., 2002) and estimated the activity of the
kinase by measuring Bcl2 (Pastor et al., 2009). Since more than
100 μM P70i also affects PKC (Lazareno et al., 1998) we also
evaluated PKC activity by looking at Erk 1 and 2 phosphorylation
(p-Erk1/2) (Setalo et al., 2005). The level of Bcl2 is higher during
massive autophagy than in infection alone (Fig. 7E Bcl-2, compare
IAVþZ to IAV) suggesting increased p70S6K activity. P70i
decreases Bcl2 in treatment controls (Fig. 7E Bcl-2, P70i 8 and
100 μM), especially in cells with massive autophagy but not in
infected cells without zVAD (Fig. 7E Bcl-2, IAVþZþP70i 8–100 μM
and IAVþP70i 8–100 μM, respectively) indicating differences in
p70S6K activity. Inhibition of p70S6K prevents LC3-I conversion to
LC3-II only when autophagy is upregulated by zVAD in infected
cells (Fig. 7E LC3). This outcome is independent of PKC inhibition
since the loss of p-Erk1/2 at 100 μM P70i (Fig. 7E p-Erk1/2, P70i
100 μM) does not increase LC3-I in treatment control (Fig. 7E LC3,
P70i 100 μM) or during infection in the absence of zVAD (Fig. 7E
p-Erk1/2 and LC3, IAVþP70i 100 μM). Thus, as in Drosophila,
mammalian p70S6K increases autophagy when caspases are
inhibited in cells challenged with inﬂuenza virus. In this situation,
altered autophagy signaling affecting mTORC2 and p70S6K leads
to massive autophagy, which is an important component in virus-
induced cell death.
Inhibition of expanded, lethal autophagy decreases
inﬂuenza A virus titer
The reduction of virus replication can mitigate virus-induced
cell stress during infection (Levine and Kroemer, 2008). To deter-
mine the effects of expanded autophagy inhibitors on virus
infection and production we examined intracellular inﬂuenza
A virus nucleoprotein (NP) levels. Inhibition of autophagy does
not prevent infection by virus as shown by NP levels after 24 HPI
(Fig. 8A NP). Surprisingly, we observe a drastic effect on NP levels
after treatment of P70i during infection by itself and in combina-
tion with inﬂuenza-zVAD treatment where no NP is detected
(Fig. 8A NP, IAVþP70i and IAVþZþP70i). This absence of NP
when p70S6K is inhibited (P70i) may be due to the presence of a
50 terminal oligopyrimidine (TOP) sequence in the untranslated
region of NP that presumptively requires p70S6K-mediated trans-
lation (Widjaja et al., 2012). However, this is speculation and we
have not addressed the issue here.
To determine if viruses are produced during inhibition of
autophagy we infected cells with half-diluted supernatant from
each treatment condition and measured NP after 6 HPI since NP
expression at low MOI is ﬁrst observed at this time (Tripathi et al.,
2013). We diluted the supernatant to minimize the possibility of
residual inhibitors affecting virus protein expression. The level of
NP as measured by this assay would provide an estimate of
released infectious virus progeny for each condition. To test the
sensitivity of this assay we used known amounts of virus on cells.
Infection of cells with increasing MOI increases NP after 6 HPI
showing the sensitivity of this method to differences in infectious
particles (Fig. 8B NP, MOI 0.1–10). Using half diluted supernatants
from treatments we observe differences in NP level between
infection alone and infection with inhibitors. Classic autophagy
inhibitor 3MA at 5 mM slightly decreases NP levels in infected
cells without zVAD while torin1 at 20 nM increases NP (Fig. 8B NP,
compare IAV to IAVþ3 MA or IAVþT20nM). Surprisingly, NP is
detected after infection with supernatants from P70i treated cells
(Fig. 8B NP, IAVþP70i and IAVþZþP70i) indicating successful
primary infection of P70i treated cells and production of infectious
virus even with undetected NP in primary infected cells at 24 HPI.
Treatment with zVAD does not change NP level compared to
infection alone (IAV) but 3MA with zVAD slightly decreases NP
while torin1 at 20 nM (T20) dramatically decreases NP levels in
inﬂuenza-zVAD treated cells (Fig. 8B NP, compare IAVþZ to
IAVþZþ3MA or IAVþZþT20 nM). Expanded, lethal autophagy
inhibitors 20 nM torin1 and 3MA reduce infectious virus release
during infection with zVAD while no change is observed after P70i
treatment as estimated by our assay using initial NP expression.
Another means of approximating the presence of infectious
virus is to examine cytopathology after infection. After infecting
cells with half-diluted supernatants and incubating them for
24 HPI, we observe considerable cytopathic effects on cells treated
with supernatants from all samples except in inﬂuenza-zVAD-
torin1 20 nM treatment (Fig. 8C, IZT) again indicating infectious
virus production during inhibition of autophagy except in infected
cells with zVAD and torin1 20 nM. Furthermore, infectious virus
production in primary infected cells after 48 HPI as measured by
plaque assay is lowered the most by treatment of inﬂuenza-zVAD
cells with 20 nM torin1, followed by P70i and 3MA (Fig. 8C graph).
Autophagy inhibition by 3MA in infection without zVAD also
decreases titers. Since released infectious virus progeny as esti-
mated by NP (Fig. 8B) is consistent with plaque assay titers from
inﬂuenza-zVAD cells with 20 nM torin1 or 3MA but not after P70i
treatment where plaque forming progeny is also on decline, the
assay in Fig. 8B appears to measure general infectious progeny but
not plaque forming virus. The consistent decrease of virus titer
during inhibition of autophagy in zVAD-treated cells indicates that
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Fig. 8. Inhibition of inﬂuenza-zVAD induced autophagy lowers virus production. Autophagy inhibitors 3MA, 20 nM torin1 (T 20 nM) and apoptosis inhibitor zVAD (Z) do not
prevent primary infection as shown by western blot of intracellular NP after 24 HPI (A NP). Infection with treatment supernatants, as estimated through NP in cells after
6 HPI, indicates successful primary infection and infectious virus production in all treatments even with undetected NP at 24 HPI (B NP). Levels of NP at 6 HPI vary with
increasing inﬂuenza multiplicity of infection (MOI) indicating the sensitivity of this assay to differences in infectious particles (B NP, MOI 0.1–10). Treatments with half-
diluted supernatants from each treatment condition for 24 HPI all show cytopathic effects except inﬂuenza-zVAD-torin1 20 nM (IZT) indicating primary infection and virus
production. Plaque assay from supernatants of 48 HPI treated cells show reduction of infectious, plaque forming virus after treatment with apoptosis and autophagy
inhibitors (C graph) especially zVAD-torin1 20 nM (IZ T20nM) followed by zVAD-P70i (IZ P70i) and zVAD-3MA (IZ 3MA).
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increased autophagy in the absence of apoptosis contributes to the
production of infectious, plaque forming inﬂuenza A virus.
Inhibition of mTOR/p70S6K decreases death during lethal autophagy
Inhibition of expanded autophagy by 20 nM torin1 or P70i
during infection with zVAD decreases cell death after 48 HPI
(Fig. 9) with torin1 conferring more protection than mTOR inde-
pendent P70i (Fig. 9, compare þ IAVþZ to þ IAVþZþT or þ IAVþ
ZþP8/P25). The inhibitors themselves (Fig. 9  IAV: T, R, P8, P25, Z,
ZT, ZR, ZP8, and ZP25) show minimal cell death, similar to mock-
infected samples (Fig. 9-IAV M). Surprisingly among other inhibi-
tors, 20 nM torin1 by itself also protects against virus-induced
death (þ IAVþT) that correlates with increased protective autop-
hagy after 20 nM torin1 treatment (Figs. 7D and S1). Rapamycin by
itself, to a lesser extent compared to torin1, also protects against
virus-induced death (þ IAVþR). These results show that inhibition
of expanded autophagy, which occurs during caspase inhibition,
using mTOR/P70 S6K inhibitors protects against inﬂuenza virus-
induced cell death while mTOR inhibition, which increases protec-
tive autophagy during apoptosis, limits virus cell killing.
Discussion
Most authors consider that inﬂuenza virus activates apoptosis
so that it can complete the maturation of virus proteins. The
maturation of NP is achieved by caspase activity (Zhirnov et al.,
1999; Zhirnov and Klenk, 2009). Extrinsic, as shown by caspase
8 cleavage (Fig. 2C), and intrinsic apoptotic pathways through
cytochrome C (McLean et al., 2009) are activated as autophagy
increases during infection. However, little is known about autop-
hagy regulation during inﬂuenza A virus infection. Here we show
that autophagy is induced even as acutely infected cells undergo
apoptosis, the default death pathway during infection. As docu-
mented here, inﬂuenza can also induce massive functional autop-
hagy through alternative signaling involving mTORC1/2 and
p70S6K, as can be seen particularly when apoptosis is blocked.
Furthermore, we show that virus is still produced during massive
autophagy and suppressed the most by the combination of
apoptosis–autophagy inhibitors.
Acute infection simultaneously triggers both apoptosis and
autophagy while autophagy without cytotoxicity is observed with
primary infection using low MOI (Zhou et al., 2009). Inﬂuenza A
virus-induced autophagy depends on canonical autophagy signal-
ing requiring Beclin-1, ATG 5 and LC3 proteins (Zhou et al., 2009).
Presumptively, the low level of autophagy during acute infection
(Fig. 1) leads to protection against immediate induction of cell
death (Fig. S1); though ultimately inﬂuenza infected cells succumb
to apoptotic death (Fig. 2). Active caspases and autophagosomes
both appear by 8 HPI, and caspase activity continues to increase
while autophagy remains low to moderate. Moderate autophagy
delays cell death during inﬂuenza infection since inhibition of
autophagy increases active caspase 3 (Fig. 5B aCaspase 3) and
secondary necrosis (Gannage et al., 2009). The role of autophagy in
inﬂuenza A virus replication during infection with apoptosis is
unclear since autophagy deﬁciency decreases viral RNA (Gannage
et al., 2009) and protein (Gannage et al., 2009; Zhou et al., 2009)
but have no effect on release of infectious virus (Gannage et al.,
2009). Moreover, we show that increased autophagy with lyso-
some turnover in zVAD-treated infected cells does not affect
production of infectious virus (Fig. 3F).
The relationship between virus protein synthesis and autop-
hagy, cell stress and virus production is quite complex as shown by
P70i treatment on inﬂuenza-infected cells. The drastic effect of
P70i on NP has never been described in literature (Fig. 8A).
However, the signiﬁcance of this alteration in virus life cycle and
production is too complex to include in this study of autophagy
signaling during infection. Here we take the opportunity to
present this interesting link between p70S6K and viral protein
expression for future studies on host–virus interaction.
The role of autophagy is revealed in the absence of inﬂuenza-
induced apoptosis where pharmacological inhibition of autophagy,
especially by 20 nM torin1 (Fig. 7D), greatly reduces infectious
virus progeny but only moderately during infection alone (Fig. 8C
graph). The effect of autophagy on infectious virus production may
be limited by apoptosis since autophagy expands during infection
with zVAD but is induced only moderately in infected cells with
apoptosis. Since high level of NP is observed in infected cells with
zVAD and 20 nM Torin1 (Fig. 8A NP, IAVþZþT 20 nM) the
decrease in infectious virus after inhibition of autophagy may be
due to disruption of infectious particle release from infected cells
Fig. 9. Inhibition of mTOR/P70 S6K decreases virus-induced death. Cell death assay by trypan blue exclusion after treatment of MDCK cells with 20 nM torin-1 (T) for
mTORC1/2, 50 nM rapamycin (R) for mTORC1 or P70i (P8¼8 μM, P25¼25 μM) for P70 S6K inhibition during MOI 5 infection (þ IAV) without or with 50 μM zVAD (Z) after
48 HPI. Mock infection (M) do not show death while infection without inhibitors (() þ IAV) show high levels of cell death. Asterisks indicate signiﬁcant differences
(*Po0.05, **Po0.01 and ****Po0.001).
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or production of immature virus. Furthermore, this ﬁnding sup-
ports the explanation that inhibition of autophagy by torin1 is not
an artifact derived from decreased intracellular virus production.
Other regulatory mechanisms control autophagy in inﬂuenza-
infected cells (Fig. 10). Activation of mTORC1 leads to inhibition of
autophagy (Corradetti and Guan, 2006; Ravikumar et al., 2010;
Pattingre et al., 2008). Inﬂuenza A virus infection activates
mTORC1 at 6–10 HPI (Fig. 6C p-mTOR), in conjunction with
increase in autophagosomes and caspase activity (Figs. 6C LC3
and 2E PARP). The activation of mTORC1 does not stop caspases
from cleaving substrates (e.g. PARP), a critical process in apoptosis.
Active mTORC1 phosphorylates various substrates to synchronize
catabolic and anabolic processes (Ravikumar et al., 2010; Nicklin
et al., 2009). When autophagy is blocked by mTORC1 inhibition of
ULK1–ATG 13–FIP200 complex (Corradetti and Guan, 2006), a
broad mTORC1 phosphorylation of translation regulators like
p70S6K occurs (Ravikumar et al., 2010; Nicklin et al., 2009;
Alexander et al., 2010). On the other hand, the phosphorylation
of p70S6K decreases during autophagy (Ravikumar et al., 2010).
Thus the phosphorylation of mTORC1 substrates, like phosphorylation
of mTORC1 itself, can be used as a mark of autophagy inhibition by
mTORC1 (Fig. 10 left panel). We observe this increase in phos-
phorylated mTORC1 with modest phosphorylation of p70S6K
during moderate autophagy after infection without zVAD (Fig. 6C
p-p70S6K). Treatment of infected cells (i.e. infection with no
zVAD) with mTOR inhibitor torin1 at inhibitory concentrations
for mTORC2 slightly increases LC3-II (Fig. 7D LC3, IAVþT 20 nM)
indicating an effect on mTORC1. Surprisingly, 20 nM torin1 pro-
tects against inﬂuenza-induced death (Fig. 9 þ IAVþT) without
inhibiting virus infection and production (Fig. 8). Although mTOR
phosphorylation is high at early time points, mTORC1 may not
play a dominant inhibitory role on the induction of autophagy in
this situation (Fig. 10 middle panel, moderate autophagy) since
mTORC1 inhibition with 4 nM torin1 or 50 nM rapamycin did not
increase autophagy during infection alone (Fig. 7B LC3, compare
IAV to IAVþR or IAVþT 4 nM).
However, when inﬂuenza-induced apoptosis is inhibited, autop-
hagy increases massively and leads to cell death (Fig. 4) in an ATG5
dependent manner (Fig. S1). Massive autophagy when apoptosis
is inhibited occurs in the absence of mTORC1 activation (Fig. 6B
Fig. 10. Regulatory signaling of autophagy during inﬂuenza A virus infection. (Left panel) Regulation of autophagy by PI3K and mTOR signaling occur during starvation,
hypoxia, or deprivation of insulin or growth factor. Many of the pathways triggered by different inducers converge on mTORC1, an inhibitor of autophagy. mTOR can either
form mTORC1 (with Raptor, mLST8, and PRAS40) or mTORC2 (with Rictor, mLST8, SIN1, and PROTOR). The presence of essential amino acids (eAA) during nutrient rich
conditions activates mTORC1. Insulin, the mammalian master hormone of the fed state activates PI3K class 1 (PI3K1) through cytoplasmic insulin receptor (IR), which in turn
leads to a cascade involving Akt that eventually activates mTORC1. Active mTORC1 prevents ULK1 mediated ULK1–ATG13–FIP200 phosphorylation, which triggers
autophagy. PI3K signaling, mTORC1 or Erk can phosphorylate p70S6K. Phosphorylation of p70S6K, which can feed back to PI3K activation, decreases during autophagy.
mTORC2 can also activate Akt. Numerous autophagy related proteins or ATGs form complexes for autophagosome formation. Breakdown of engulfed contents by proteases,
glycosidases, nucleases and lipases occur through autophagosome fusion with the lysosome. Lysosome permeases (LP) release amino acids, lipids, nucleosides, and
carbohydrates back to the cytosol for use in synthetic and metabolic pathways. Protective and lethal autophagy differs in PI3K/mTOR signaling. Transient PI3K activity
leading to Akt phosphorylation followed by mTORC1 activation occurs during moderate autophagy (middle panel). Low-level p70S6K phosphorylation is also observed.
Autophagy then progresses with increased autophagosome formation and early activation of lysosomes. Massive autophagy (right panel) exhibits increased and prolonged
Akt phosphorylation. However, this does not translate to mTOR phosphorylation at Serine 2448 and we only observe transient mTORC1 activation; instead an abrupt
activation of mTORC1 is followed by dephosphorylation. mTORC2, which is reported to increase in the absence of mTORC1, compliments PI3K-mediated Akt phosphorylation
during massive autophagy. Although mTORC1 lacks Serine 2448, mTORC1-mediated p70S6K phosphorylation still occurs. mTORC2 also contributes to the regulation of
p70S6K activity during massive autophagy. In this situation, inhibition of p70S6K activity or mTORC2 prevents massive, lethal autophagy. The number of steps (n) and nature
of p70S6K regulation of autophagy remain unknown (see Discussion). Delayed activation of lysosomes is also observed. Viral and host components that trigger these changes
are currently being identiﬁed.
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p-mTOR). Cells undergoing autophagic death have suppressed
mTORC1 signaling (Suh et al., 2010). Furthermore, mTORC1 substrate
p70S6K, which is robustly phosphorylated at early times in infected,
zVAD treated cells, is no longer phosphorylated by 24 HPI (Fig. 6B
p-p70S6K) when autophagy is maximized as deﬁned by a sharp
increase in LC3-II (Fig. 6B LC3). Although this increase in phosphor-
ylation of p70S6K at Threonine 389 is under mTORC1 regulation
(Fig. 7A p-p70S6K) the limited effect of mTORC1 inhibition on lethal
autophagy (Fig. 7B LC3), persistent p70S6K phosphorylation after
4 nM torin1 treatment (Fig. 7A p-p70S6K) and reduction of p70S6K
activity after mTORC2 inhibition (Fig. 7D Bcl-2) indicate that p70S6K
may be targeted by both mTORC1 and mTORC2 during lethal
autophagy (Fig. 10 right panel, massive autophagy). The increased
level and early kinetics of p-p70S6K during massive autophagy
suggests a regulatory role in induction. Thus a non-inhibitory mTOR
signaling may be active when inﬂuenza-induced apoptosis is inhib-
ited and massive autophagy is induced.
Increased p70S6K phosphorylation is observed with increased
p-Akt (Fig. 6B p-Akt). The activation of mTORC1, PI3K, mTORC2 or
Erk has been shown to affect p70S6K phosphorylation at Threonine
389, an essential component of p70S6K activity (Vanhaesebroeck
and Alessi, 2000; Han et al., 1995). However, constant levels of
p-Erk1/2 during massive autophagy (Fig. 7E p-Erk1/2) cannot
explain the sustained increase of p-p70S6K at Threonine 389.
Furthermore, mTOR phosphorylation at Serine 2448, which acti-
vates mTORC1, is suppressed during massive autophagy (Fig. 6B
p-mTOR) while PI3K/mTORC2 activity as measured by Akt phos-
phorylation is increased and correlates with p70S6K phosphory-
lation (Fig. 6B p-Akt). We observe that mTORC1 still regulates
p-p70S6K during inﬂuenza-zVAD-induced autophagy (Fig. 7A
p-p70S6K). In addition to mTORC1, mTOR in the form of mTORC2
also regulates p70S6K during autophagy (Fig. 7D Bcl-2). Inhibition
of mTORC2 by torin1 at 20 nM decreases p70S6K activity and
successfully blocks massive autophagy in infected cells with zVAD
(Fig. 7D Bcl-2 and LC3) demonstrating an alternative role for
mTORC2 as a stimulator of autophagy (Fig. 10 right panel, massive
autophagy). Inhibition of lethal autophagy by 20 nM torin1 also
correlates with decreased virus-induced death during caspase
inhibition (Fig. 9 þ IAVþZT). Furthermore, a more direct inhibition
of p70S6K activity with bis-indolylmaleimide V (P70i), an mTOR
independent p70S6K inhibitor (Marmy-Conus et al., 2002) pre-
vented LC3-I conversion to LC3-II, a critical process in autophago-
some formation, in the situation of massive autophagy (Fig. 7E LC3).
Treatment with P70i also decreases cell death during lethal autop-
hagy (Fig. 9). Thus in this situation loss of mTOR Serine 2448
phosphorylation correlates with increased mTORC2 activity and
mediated p70S6K activation, suggesting alternate pathways for
p70S6K activation that do not require mTOR phosphorylation at
Ser 2448 (Fig. 10 right panel, massive autophagy). Since both
mTORC2 and p70S6K inhibition effectively inhibit autophagy in
inﬂuenza-zVAD treated cells these two kinases may belong to a
common signaling pathway or affect critical autophagy pathways
(Fig. 10 right panel, massive autophagy). The phosphorylation of
p70S6K determines the amount of autophagy in Drosophila (Scott
et al., 2004), which we also observe in massive autophagy of MDCK
cells. Expression of activated Drosophila p70S6K can increase the
rate of autophagy in cells experiencing chronic target of rapamycin
(TOR) inactivation but not in cells undergoing short-term autophagy
(Chang et al., 2009). A subtle difference in autophagy regulation
exists between TOR inactivation by truncation and TOR knockout,
where TOR inactivation selectively increases autophagy during
nutrient rich situations unlike TOR knockout mutants that increase
autophagy indiscriminately (Scott et al., 2004). This selective
induction by inactive TOR resembles our observation in zVAD
treated infected MDCK cells (Fig. 6B p-mTOR and p-p70S6K) where
loss of Serine 2448 and not loss of mTORC1 activity correlates with
increased p-p70S6K and massive autophagy. Moreover, inhibition of
mTORC1 that lack p-mTOR inadequately prevents lethal autophagy
unlike direct p70S6K inhibition or mTORC2 inhibition. p70S6K may
have autophagy related functions that do not depend on mTORC1-
mediated activation at Threonine 389. Thus, it appears that the role
of p70S6K during massive autophagy with chronic TOR inactivation
is conserved in Drosophila and mammals.
We propose that increased and prolonged autophagy requires
the translation of several components of the autophagosome.
Critical autophagy proteins increase during autophagy (Wong
et al., 2010). Inhibition of protein synthesis disrupts expansion of
autophagosomes (Abeliovich et al., 2000) and lysosomal turnover
(Lawrence and Brown, 1993). Various autophagy-related proteins
(ATG) possess target sequences called 50 terminal oligopyrimidine
tracts (50 TOP) for p70S6K-mediated translation (Table 1). The
presence of this sequence composed of an invariable cytosine
succeeded by a stretch of 5–14 pyrimidines (i.e. cytosine and uracil)
of mRNA allows S6 ribosome/polyribosome binding and consequent
translation of the bound transcript (Levy et al., 1991; Jefferies et al.,
1997; Yamashita et al., 2008). The translational control for different
50 TOP mRNAs is the same regardless of pyrimidine count (Avni
et al., 1994). LC3/ATG8, a critical autophagy protein, possesses a 50
TOP sequence and is highly expressed even in GFP-LC3 form during
massive autophagy (Fig. 5Ad). This increased expression of GFP-LC3,
the presence of 50 TOP in several critical autophagy related proteins,
and the importance of p70S6K activity in induction of massive
autophagy collectively suggest that increased p70S6K activity
increases levels of autophagy due to increased ATG translation.
We are currently exploring this possibility.
Table 1
Terminal Oligopyrimidine Tract (TOP) in untranslated region of mRNA for various
autophagy related proteins.
Protein Nucleotides before start codon Sequence
ATG8/LC3 33–25 CUUUUUU
ATG3 43–38 CUUUCC
ATG5 333–328 CUUUUU
314–309 CUUCCU
ATG7 99–94 CUUCCC
ATG4 442–437 CUCCUU
414–409 CCUUUU
339–334 CUUUCU
323–317 CCUCUUC
237–230 CUCCUCCU
160–155 CCUUUU
145–139 CUCUUCU
ATG10 185–176 CUCUUCCUCC
97–88 CCCUCUCCCC
85–73 CUCUCCUCCCCCU
ATG12 81–72 CUCCUCUCCC
ATG16 107–102 CUUUUU
ATG13 626–606 CUCUCUCUCUCUCUCUC
597–591 CCUUUCC
429–421 CCCUCUUUC
419–408 CCCCCCCCCCCC
222–216 CCCUUCU
92–87 CUCUUU
37–32 CCUCCU
UVRAG 188–180 CUCUUCCUU
112–107 CCUCUC
Ambra1 45–39 CUCCUUC
Bcl-2 455–450 CCUCCU
441–430 CUCCCUCUCCCC
134–128 CCCCCUC
83–68 CUCCUCUUCUUUCUCU
17–8 CUUUUCCUCU
ATG6/Beclin1 150–142 CUUUUUU
ATG14/Baktor 18–9 CUCUCCUCUC
Data is reproduced from UCSC genome database (Meyer et al., 2013).
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Autophagy is completed as autophagosomes fuse with lyso-
somes to degrade cargo (Corradetti and Guan, 2006; Ravikumar
et al., 2010; Pattingre et al., 2008). Increase in autophagosomes
during zVAD treatment was previously attributed to lysosome
disruption by zVAD that leads to loss of turnover or ﬂux of
autophagy (Lockshin and Zakeri, 2002; White, 2008). We show
here that delay in lysosome activation, not permanent inhibition of
lysosomes, occurs during infection when apoptosis is inhibited by
zVAD (Fig. 4D). Lysosome activity is high when autophagy is
increased and autophagosomes of different stages of degradation
are observed in caspase-inhibited infected cells (Fig. 4C). Delayed
lysosome activation when autophagy is increased can lead to
buildup of autophagosomes but these autophagosomes remain
functional, as documented by turnover of autophagosomes even
when autophagy is very high (Fig. 4E), consistent with ﬁndings on
zVAD-induced autophagy in other cell types (Wu et al., 2008).
To summarize, we demonstrate that the protective and lethal
aspects of autophagy can be examined in inﬂuenza A virus infected
cells. Protective autophagy is characterized by moderate induction
with mTOR phosphorylation (i.e. mTORC1 activation) and immedi-
ate lysosome activation. In contrast, the absence of mTOR Serine
2448 phosphorylation concomitant with increased mTORC1/
mTORC2 mediated p70S6K activity, increased LC3, delayed
increase in lysosome activity and exacerbation of autophagosome
accumulation typiﬁes massive, unrestrained autophagy.
It may be possible to limit the pathology of inﬂuenza A virus
infection by simultaneous blockage of apoptosis and autophagy
since inhibition of both processes drastically lowers virus produc-
tion. Instead of focusing only on targeting components of canonical
autophagy signaling, inhibition of mTORC2 or p70S6K activity
should also be employed in conjunction with other inhibitors.
Although we do not observe adverse effects by mTORC2/P70 S6K
inhibition and zVAD treatment in our system (Fig. 9), examination
of toxicity dose curves on different cell types and in-vivo models
would reduce potentially lethal side effects by these inhibitors. For
example, prolonged exposure with lower doses of P70i can still
decrease cell death during lethal autophagy (Fig. 9) and limit
autophagy (data not shown) without being toxic. Moreover, certain
cells like those in the preimplantation fertilized ova of mice
undergo cell death in the presence of zVAD (Zakeri et al., 2005)
emphasizing the importance of toxicity studies. In conclusion, the
main mechanism of cell death or loss during inﬂuenza A virus
infection is apoptosis, but apoptosis does not explain persistent
virus-induced cell death. The decision whether autophagy takes a
moderate or excess route depends on what pathways are activated
during stress, increased mTORC2/p70S6K dependent signaling is a
route to excessive activation of apparently overwhelming, lethal,
unrestrained autophagy. Whether this regulation is part of a
situation called autophagic programmed cell death (Tsujimoto and
Shimizu, 2005) remains to be determined. A proportion of cells
during infection after apoptosis and autophagy inhibition still die
through an unidentiﬁed alternative means indicating the redun-
dancy of death mechanisms in cells. The question of other uni-
dentiﬁed programs of cell death aside from apoptosis, autophagic
death or necroptosis lingers to this day. Regardless of the complex-
ity of cell death, how a shift of autophagy between a protective and
a lethal role is controlled, and whether this shift can be inﬂuenced,
remains a fruitful subject of study.
Materials and methods
Cell culture and treatment
Madin-Darby Canine Kidney (MDCK) (a gift of Dr. Anastasia
Gregoriades, Queens College, Flushing, NY), ATG 5 KO mouse
embryonic ﬁbroblasts (ATG5 MEF) (a gift of Dr. Patrizia Agostinis,
Catholic University of Leuven, Belgium) and MCF7 (ATCC#HTB-22)
cells were maintained in Dulbecco0s Minimum Essential Media
(DMEM) with 10% FBS, 50 U/ml penicillin and 50 mg/ml strepto-
mycin at 37 1C under a 5% CO2 atmosphere. Final concentration of
5 mM L-glutamine was added to the ATG5 MEF media. Prior to all
infections, cells were seeded and allowed to attach overnight in
maintenance media. Cells were washed with 1 Phosphate
Buffered Saline (PBS) before infecting at multiplicity of infection
(MOI)¼5. Sufﬁcient virus was added by diluting virus stock with
ice-cold virus diluting media (PBS with 0.2% BSA, 1 mM MgCl2,
0.9 mM CaCl2, 50 U/ml penicillin and 50 mg/ml streptomycin) and
adding to cells for 1 h at room temperature. Cells were then
washed once with 1 PBS and covered with DMEM with 5% FBS,
and incubated at 37 1C, 5% CO2 until data collection.
Inﬂuenza A virus (A/WSN/33), described below as WSN, was
generously provided by Dr. Garcia-Sastre (Mount Sinai Medical
School, NY). For expansion of inﬂuenza stocks, 10-day-old speciﬁc-
pathogen-free embryonated chicken eggs (Charles River SPAFAS,
North Franklin, CT) were infected with virus and incubated at
35 1C for 2 days. Allantoic ﬂuid from infected eggs was spun at
3000 rpm for 5 min, then stored at 80 1C. Viral titers of inﬂuenza
stock solutions were determined by plaque assay as described
previously (Han et al., 1995). Brieﬂy, monolayers of MDCK cells
were incubated overnight in DMEM containing 10% FBS and 1%
pen-strep. This was followed by infection with 10-fold serial
dilutions of virus suspension for 1 h at room temperature. Cells
were then covered with warmed Eagle0s minimum essential
medium (#12-668E, BioWhittaker) containing 0.1% DEAE–dextran
(#D9885, Sigma-Aldrich) and 2% puriﬁed agar (#LP0028, Oxoid).
This agar medium was allowed to solidify at room temperature
and the cells were incubated for 2 days at 37 1C for plaque
development. Prior to analysis the solidiﬁed agar was removed,
and the cells were ﬁxed and stained with a methanol–crystal
violet solution. Plaques were counted, and the virus titer was
expressed as PFU/ml.
When appropriate, pancaspase inhibitor zVAD-fmk (zVAD) (#BML-
P416-0001, Biomol International) was applied at 50 μM ﬁnal
concentration (Lockshin and Zakeri, 2002), class I/III PI3K inhibitor
Wortmannin (wort) (#681675, Calbiochem) at 20–40 μM (McLean
et al., 2011; Ravikumar et al., 2010), class III PI3K inhibitor
3-methyladenine (3 MA) (#M9281 Sigma) at 5–20 mM (Zhou
et al., 2009; McLean et al., 2011; Levine and Kroemer 2008),
necroptosis inhibitor necrostatin (lot#F0712, Santa Cruz Biotech-
nology) at 50–200 μM (Degterev et al., 2005), mTOR inhibitors
rapamycin (#R0395, Sigma) at 50 nM (McLean et al., 2011; Levine
and Kroemer 2008) and torin1 (#4247, R&D) at 4 or 20 nM
(Ravikumar et al., 2010; Liu et al., 2010) and p70S6K inhibitor
bis-indolylmaleimide V (p70i) (lot#D00074865, Calbiochem) at
8–100 μM (Marmy-Conus et al., 2002). In these cases, cells were
incubated with inhibitors for 1 h prior to infection. Lysosome
cathepsin D inhibitor pepstatin A (lot#D00103354, Calbiochem)
was added at 10 μg/ml of media after infection (Lockshin and Zakeri
2002; McLean et al., 2011). Inhibition by zVAD (Figs. 3B and C, and
5B), Wortmannin (Fig. 5A–C), 3MA (Fig. 5D), rapamycin (Fig. 7A),
torin1 (Fig. 7C) and p70i (Fig. 7E) was experimentally veriﬁed.
Assessment of cell viability and death
Cells were infected with inﬂuenza A virus at MOI¼5. The cells
were incubated for 1 h at room temperature, washed once with
1 PBS and covered with maintenance media at 37 1C, 5% CO2 and
harvested at various times. Infected cells were collected by trypsin
digestion, and stained with 0.4% trypan blue in 1 PBS; exclusion
of trypan blue correlates well with other viability assays. Live
(white) and dead (blue) cells were counted on a hemocytometer,
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with cell viability expressed as percent dead cells above the
percent found in mock-infected cultures. Mock-infection is treat-
ment with virus media without virus then addition with new
media as an equivalent to 0 HPI or uninfected cells. Experiments
were done in triplicate and the Student T-test was used to
determine signiﬁcant differences in cell death.
To assess apoptosis, nuclear and DNA fragmentation were
determined. DNA ﬂuorochrome bis-benzimide (Hoechst 33258)
was used to assess the amount of nuclear fragmentation in
infected cells as described previously (McLean et al., 2009).
Fragmented nuclei were counted using a Leitz DMRB ﬂuorescence
microscope. Nuclei that had fragmented into small dense bodies
were considered apoptotic while nuclei with evenly dispersed
chromatin were non-apoptotic.
For DNA cleavage cells plated at a density of 7106 cells were
infected with virus and collected for DNA extraction at various HPI.
After scraping of cells and centrifugation the pellet was resus-
pended with 0.5 ml lysis buffer (10 mM Tris–HCl at pH 7.5, 10 mM
EDTA at pH8.0, and 0.2% Triton X-100) and incubated on ice for
15 min. Lysate was centrifuged at 12,000g for 20 min. and the
supernatant was treated with 5 ml RNase A (100 μg/ml) and
incubated at 37 1C for 1 h. DNA was puriﬁed by phenol extractions
and precipitated overnight by 2.5 volume of 100% ethanol.
Resuspended DNA was run on a 2% agarose gel and viewed with
a UV transluminator for detection of DNA laddering (Karasavvas
and Zakeri, 1999).
Transmission electron microscopy (TEM)
Reagents were purchased from Electron Microscopy Sciences
(Fort Washington, PA). MDCK cells were plated at a density of
1.5106, infected with inﬂuenza virus at a MOI of 5 with or without
treatment. After 24 HPI, cells were ﬁxed in 2.5% glutaraldehyde in
0.2 M cacodylate buffer, pH 7.4 for 20 min at room temperature (RT)
on the plate. Cells were then scraped off and centrifuged in conical
tubes at 1200g for 5 min. After washing in cacodylate buffer cells
were post-ﬁxed with 1% osmium tetroxide in the same buffer for
1 h at RT and washed again. Cells were then dehydrated through
ascending ethanol concentrations (50–100%) for 10 min each and
embedded in Agar 100 epoxy resin. Sections were counterstained
with lead citrate and uranyl acetate. High-resolution images were
taken with a Philips 208 electron microscope.
Western blot and cytochemistry
Cells were infected and treated as described above. Western
blot analysis was performed as described by Lin et al. (2006).
Brieﬂy, treated cells were scraped and washed with ice-cold 1
PBS before whole cell lysate proteins were collected in RIPA buffer
and quantiﬁed using the BioRad protein assay and an Ultrospec III
spectrophotometer (Pharmacia LKB, Sweden). Western blot analy-
sis was performed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE), using primary antibodies: anti-active
caspase 3 (#559565, BD Pharmingen), anti-caspase 3 and anti-
cleaved caspase 8 (both graciously given by Donald Nicholson,
Merck Frosst, Canada), anti-PARP (# sc7150, Santa Cruz Biotech-
nology), anti-LC3 (# L7543, Sigma-Aldrich), anti-phosphorylated
Akt (#9271S), anti-Akt (#9272S), anti-phosphorylated mTOR (#D9C2),
anti-mTOR (#7C10), anti-phosphorylated p70S6K (#108D2), anti-
p70S6K (#2708), anti-phosphorylated Erk1/2 (#4377, all from Cell
Signaling), anti-Bcl2 (#sc492), and anti-β-tubulin (# sc9104, loading
control, both from Santa Cruz ), α-tubulin (#t6074, Sigma-Aldrich),
and anti-inﬂuenza α-NP protein (graciously given by Dr. Adolfo
Garcia Sastre, Mount Sinai, NY). Positive signals were detected using
ECL (#RPN2132, GE Healthcare) and visualized using an Amersham
Hyperﬁlm ECL photoradiographic ﬁlm (# 28906835, GE Healthcare) or
a Typhoon 9410 Variable mode Imager (GE Healthcare).
Cytochemical analysis was performed as described by Lin et al.
(2006). Cells were seeded on ﬂame-sterilized glass cover slips,
allowed to attach overnight, infected and treated as above. After
treatment 24 HPI, cells were washed with 1 PBS and ﬁxed with
fresh, ice-cold 3% paraformaldehyde for 10 min, washed once and
stored in 1 PBS in dark at 4 1C. Cells were transfected with GFP-
LC3 plasmid (provided by Guido Kroemer, Institut Gustave-Roussy,
Villejuif, France) using the Lipofectamine 2000 system (# 52887,
Invitrogen) according to manufacturer0s protocol. Post-transfec-
tion, cells were incubated at 37 1C for at least 16 h before collection
or treatment to allow plasmid expression. LC3-GFP expressing
cells were embedded immediately following ﬁxation. For both
situations cells were embedded by Gel Mount (#M-01, Biomeda)
and observed by confocal microscopy (Leica, Germany).
For measurements of lysosomal activity, cells were infected and
collected as described above. The activity of the lysosomal enzyme
acid phosphatase was assessed using an acid phosphatase assay kit
(#CS0740, Sigma) according to the manufacturer0s protocol and
106 cells from each sample. The absorbance of each sample at
405 nm was measured spectrophotometrically with an Ultraspec
III spectrophotometer (Pharmacia LKB, Sweden).
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